Punjab Chemicals revenue rises 8.7% in Q1FY27 on export surge
Punjab Chemicals delivered strong Q1FY27 results with revenue rising 8.7% to ₹347.2 Cr, led by an export surge. EBITDA expanded 18.8% to ₹40.8 Cr, though PAT growth was more modest at 7.0% due to lower other income.

*this image is generated using AI for illustrative purposes only.
Punjab Chemicals & Crop Protection reported an 8.7% year-on-year increase in consolidated revenue for Q1FY27, driven primarily by a sharp rise in international sales. The agrochemical manufacturer delivered robust operating leverage, with EBITDA growing 18.8% to ₹40.8 Cr and margins expanding to 11.8%, signaling improved operational efficiency and a favorable product mix.
The company filed its investor presentation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, detailing the financial performance for the quarter ended June 30, 2026. The results reflect a strategic shift towards higher-value intermediates and successful commercialization of new products, which contributed 14% of total revenue in the quarter.
Financial Performance Highlights
Revenue from operations stood at ₹347.2 Cr in Q1FY27, compared to ₹319.5 Cr in the corresponding period of FY26. This growth was underpinned by a significant increase in international sales, which rose to ₹157 Cr from ₹124 Cr YoY, while domestic revenue remained relatively stable at ₹190 Cr (down slightly from ₹196 Cr). Gross margins expanded by 350 basis points to 36.6% from 33.1% YoY, attributed to efficiency gains, price increases, and an improved product mix.
| Metric | Q1FY27 | Q1FY26 | YoY Change |
|---|---|---|---|
| Revenue (₹ Cr) | 347.2 | 319.5 | +8.7% |
| EBITDA (₹ Cr) | 40.8 | 34.4 | +18.8% |
| EBITDA Margin | 11.8% | 10.8% | +100 bps |
| PAT (₹ Cr) | 22.1 | 20.6 | +7.0% |
| PAT Margin | 6.4% | 6.5% | -10 bps |
Profit after tax (PAT) increased by 7.0% to ₹22.1 Cr, with earnings per share (EPS) rising to ₹18.0 from ₹16.8 in the prior year quarter. Despite the PAT growth, the PAT margin contracted slightly by 10 basis points to 6.4%, indicating that while top-line and operating profits grew strongly, tax expenses or other income variations moderated the bottom-line margin expansion.
Strategic Developments and Growth Drivers
The company highlighted several strategic initiatives contributing to its current performance and future outlook. New products, particularly intermediates for agrochemicals, have been successfully commercialized with more efficient processes. Management expects volume growth for these new products to reach 100% in the current financial year. Additionally, commercial lots have been supplied for two of three Memorandum of Understanding (MoU) products, with volume pick-up anticipated from Q4FY27 onwards.
Looking ahead, Punjab Chemicals plans to launch two intermediate herbicide products in the domestic market during Q3/Q4FY27. The company is also actively scouting for a new production site to support its expanding operations and product range. A capex of approximately ₹100 crore has been earmarked for two multi-purpose plants over the next two to three years, aimed at catering to both domestic and export markets.
What the Numbers Show
The divergence between the strong EBITDA growth (18.8%) and moderate PAT growth (7.0%) warrants attention. While operational efficiencies drove significant margin expansion at the gross and EBITDA levels, the net profit margin saw a slight contraction. This suggests that while core operations are performing well, factors such as tax provisions or lower other income (which fell to ₹0.7 Cr from ₹3.7 Cr YoY) impacted the final bottom line. The substantial rise in international revenue share underscores the company’s success in penetrating global markets, reducing dependency on the domestic sector.
Historical Stock Returns for Punjab Chemicals & Crop Protection
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -5.13% | +0.67% | +6.33% | -5.61% | -22.29% | -17.83% |
How might the anticipated 100% volume growth for new intermediate products in FY27 impact Punjab Chemicals' overall revenue mix and margin stability in the coming quarters?
What are the potential risks associated with the company's increasing reliance on international sales, particularly regarding currency fluctuations or geopolitical trade barriers?
How will the planned ₹100 crore capex for multi-purpose plants over the next two to three years affect the company's debt levels and return on invested capital (ROIC)?


































